Exciting news to share! Abeona Therapeutics doses the first patient in Phase 1/2 Trial with ABO-102 Gene Therapy for patients with Sanfilippo Syndrome Type A (MPS IIIA).
Read More >> http://www.marketwired.com/press-release/-2125579.htm
Helping Find a Cure for Sanfilippo Syndrome